Author Archives: Dr. Joris Wiggers

Researchers identify 74% of schizophrenia cases via brain scan data – Schizophrenia Journey

http://schizophreniajourney.com/pathogenesis/researchers-identify-74-schizophrenia-cases-via-brain-scan-data/ Researchers identify 74% of schizophrenia cases via brain scan data An intense search for a reliable biomarker takes a new turn. An intense search for a reliable biomarker takes a new turn. In the race for a reliable schizophrenia biomarker, researchers say they’ve made significant progress toward developing a way to use brain scans […]
Read More »

Urine testing in schizophrenia monitors adherence to treatment

A link to the following article(s) has been sent to you by Joris (joriswiggers). Clinical Consensus Recommendations for Urine Testing of Adherence to Antipsychotics Among People With Serious Mental Illness Thank you for using psychiatryonline.org! Sincerely, American Psychiatric Association Publishing 1000 Wilson Blvd, Suite 1825 Arlington, VA 22209 1-800-368-5777, 703-907-7322 psychiatryonline

Prazosin falls short for veterans’ PTSD-related sleep problems

Disappointing,hard to ignore study will change my practice: I don’t think Prazosin is worth a trial when other options are available and therapy is still TOC. https://www.mdedge.com/clinicalpsychiatrynews/article/158262/ptsd/prazosin-falls-short-veterans-ptsd-related-sleep-problems

What Clinicians Need to Know About Vitamins and Mineral Supplements | Complementary and Alternative Medicine | JAMA | The JAMA Network

This is the latest , fairly conservative review of supplements. Note the growing acceptance of Vt D, even from within the medical establishment. https://jamanetwork.com/journals/jama/fullarticle/2672264?utm_source=silverchair&utm_campaign=jama_network&utm_content=weekly_highlights&cmp=1&utm_medium=email Vitamin and Mineral Supplements What Clinicians Need to Know What Clinicians Need to Know Dietary supplementation is approximately a $30 billion industry in the United States, with more than 90 000 products […]
Read More »

Do Over-the-Counter Painkillers Alter Emotions, Reasoning?

https://www.medicinenet.com/script/main/art.asp?articlekey=210014&ecd=mnl_men_020718 Do Over-the-Counter Painkillers Alter Emotions, Reasoning? Latest Mental Health News TUESDAY, Feb. 6, 2018 (HealthDay News) — Sure, an over-the-counter painkiller like Tylenol or Advil can help ease aches and pains, but could it mess with your thoughts and emotions, too? That’s the finding from a new review of recently published studies. The studies […]
Read More »

Interesting medical links to bipolar disorder

Obesity in patients with major depression is related to bipolarity and mixed features: Evidence from the BRIDGE-II-Mix study Bipolar Disorders — Petri E, et al. | July 31, 2017 The link between obesity and the presence of mixed features and bipolarity was gauged during this trial. It was determined that the presence of obesity in […]
Read More »

LSD or Magic Mushrooms for Terminal Illness

Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review Progress in Neuro-Psychopharmacology and Biological Psychiatry — | January 24, 2018 Reiche S, et al. – Researchers investigated serotonergic hallucinogens for the treatment of anxiety associated with life-threatening diseases. Because of their anxiolytic and antidepressant properties, […]
Read More »

Botox for severe Depression

Botulinum toxin as a treatment for depression in a real-world setting Journal of Psychiatric Practice — | January 24, 2018 Chugh S, et al. – Researchers here aimed at furthering knowledge regarding the efficacy of glabellar botulinum toxin (BTX) injection as a treatment for depression in women and assessing how they could be translated to […]
Read More »

ECT for depression can be very successful and can be maintained.

Older patients (>55) with a psychotic depression and complete remission within the first four electroconvulsive therapy sessions are the ones with the best chance of remaining relapse free for at least 6 months (10% relapse rate vs. 63% others), presented by Pascal Sienaert, MD, PhD, reported at the annual congress of the European College of […]
Read More »

Medication enhanced psychotherapy

Propranolol May Help PTSD Patients Receiving Exposure Therapy While exposure therapy is recognized as one of the best strategies for treating patients with posttraumatic stress disorder (PTSD), many continue to experience significant problems. A study published in AJP in Advancesuggests that patients with PTSD who take propranolol (a noradrenergic beta-receptor blocker) prior to recalling their […]
Read More »